Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JER
|
|||
| Drug Name |
Tetra-substituted urea derivative 2
|
|||
| Synonyms |
PMID26413912-Compound-54
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BIAL PORTELA & CA SA [PT]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H18FN3O2
|
|||
| Canonical SMILES |
CN(C1CCCC1)C(=O)N2C=C(N=C2)C3=CC(=C(C=C3)O)F
|
|||
| InChI |
1S/C16H18FN3O2/c1-19(12-4-2-3-5-12)16(22)20-9-14(18-10-20)11-6-7-15(21)13(17)8-11/h6-10,12,21H,2-5H2,1H3
|
|||
| InChIKey |
IWRLZEZXDCIMHJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.